SORRENTO THERAPEUTICS INC (SRNE) Stock Analyst Ratings
USA - NASDAQ:SRNE - US83587F2020 - Common Stock
0.3073 USD
-0.08 (-20.26%)
0.2801 USD
-0.03 (-8.85%)
ChartMill assigns a Buy % Consensus number of 82% to SRNE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.82. This target is 2444.76% above the current price.
SRNE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SRNE.
In the previous month the buy percentage consensus was at a similar level.
SRNE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-08-09 | HC Wainwright & Co. | Maintains | Buy |
SORRENTO THERAPEUTICS INC / SRNE FAQ
What is the average price target for SORRENTO THERAPEUTICS INC (SRNE) stock?
9 analysts have analysed SRNE and the average price target is 7.82 USD. This implies a price increase of 2444.75% is expected in the next year compared to the current price of 0.3073.
What is the consensus rating for SRNE stock?
The consensus rating for SORRENTO THERAPEUTICS INC (SRNE) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for SRNE stock?
The number of analysts covering SORRENTO THERAPEUTICS INC (SRNE) is 9.